Table 4.
NHANES |
1988–1994 (n=16573) | 1999–2000 (n=4222) | 2001–2002 (n=4792) | 2003–2004 (n=4742) | 2005–2006 (n=4481) | 2007–2008 (n=5660) | 2009–2010 (n=6011) | 2011–2012 (n=5281) | 2013–2014 (n=5541) | P for trend‡ | |
No. with 4 or more comorbidities* | 2521 | 875 | 924 | 1092 | 964 | 1413 | 1398 | 1152 | 1321 | ||
Overall prevalence± | 12.0 (11.1–12.9) | 15.8 (13.7–17.8) | 15.3 (13.2–17.3) | 18.5 (16.2–20.9) | 18.4 (16.4–20.4) | 19.3 (17.0–21.6) | 18.8 (17.2–20.4) | 19.4 (17.0–21.8) | 22.7 (21.1–24.3) | <.0001 |
Un-weighted total number of subjects with 4 or more multi-morbidities
Weighted overall prevalence of 4 or more multi-morbidities
p-value from logistic regression analysis.
Chronic conditions included in determining multi-morbidity: cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), asthma, arthritis, cancer, stroke, hypertension, hyperlipidemia, diabetes, and obesity.